Because these data suggest that the LIF/LIFR pathway is modulated in PDAC tissues, we then investigated whether LIF/LIFR expression undergoes the same regulation in two pancreatic cancer lines, MIA PaCa-2 and PANC-1, which are widely used as in vitro models for PDAC [41]. The gene discussed is LIFR; the disease is pancreatic neoplasm.